HomeTGTX • NASDAQ
add
TG Therapeutics Inc common stock
Previous close
$23.51
Day range
$22.60 - $23.69
Year range
$6.47 - $25.36
Market cap
3.64B USD
Avg Volume
3.25M
P/E ratio
39.14
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 73.47M | 357.05% |
Operating expense | 56.35M | -4.23% |
Net income | 6.88M | 114.45% |
Net profit margin | 9.36 | 103.16% |
Earnings per share | 0.04 | 111.76% |
EBITDA | 8.84M | 119.79% |
Effective tax rate | -5.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 217.25M | 49.93% |
Total assets | 401.21M | 81.66% |
Total liabilities | 223.64M | 23.97% |
Total equity | 177.57M | — |
Shares outstanding | 143.45M | — |
Price to book | 18.96 | — |
Return on assets | 5.69% | — |
Return on capital | 7.84% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 6.88M | 114.45% |
Cash from operations | 5.54M | 113.18% |
Cash from investing | 1.76M | -94.21% |
Cash from financing | 135.00K | -99.71% |
Net change in cash | 7.44M | -79.08% |
Free cash flow | 1.11M | 104.35% |
About
Founded
1993
Headquarters
Website
Employees
300